PRESS RELEASE published on 11/15/2023 at 09:05, 1 year ago BioNxt Reports on New Cladrabine ODF Product Development and Commercialization Program
PRESS RELEASE published on 11/13/2023 at 09:05, 1 year ago BioNxt Signs Definitive Agreement For 100% Acquisition of IP And Co-Development of Cladribine ODF Drug Reformulation for The Treatment of Multiple Sclerosis
PRESS RELEASE published on 11/06/2023 at 09:05, 1 year ago BioNxt Solutions Reports on Barcelona CPHI Conference
PRESS RELEASE published on 10/28/2023 at 00:20, 1 year ago BioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private Placement
PRESS RELEASE published on 10/03/2023 at 22:30, 1 year 1 month ago BioNxt Solutions Announces Change of Directors
PRESS RELEASE published on 09/29/2023 at 01:30, 1 year 1 month ago Bionxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement
PRESS RELEASE published on 08/05/2023 at 02:12, 1 year 3 months ago BioNxt Solutions Announces Non-Brokered Private Placement
PRESS RELEASE published on 08/02/2023 at 09:00, 1 year 3 months ago BioNxt Signs LOI for Acquisition of IP and Co-Development of ODF Drug Reformulation for Neurodegenerative Disease
PRESS RELEASE published on 05/15/2023 at 09:05, 1 year 6 months ago BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson’s Disease
PRESS RELEASE published on 05/09/2023 at 09:05, 1 year 6 months ago BioNxt Successfully Completes Pilot Study for Contract Development Customer
Published on 11/21/2024 at 22:05, 2 hours 10 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 25 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 4 hours ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 4 hours 5 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 5 hours 14 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 39 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 6 hours 17 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours 23 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 24 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 17 hours 17 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
